Rating Change
Morgan Stanley reiterated its Equal-Weight rating on Elevance Health Inc. (NYSE:ELV) on October 22, 2026.
reiterateNYSE:ELV
Morgan Stanley Reiterates Equal-Weight Rating on Elevance Health Inc. (ELV)
Morgan Stanley reiterated its Equal-Weight rating on Elevance Health Inc. (NYSE:ELV) on October 22, 2026.
At publication ·
What changed
Elevance Health Inc. (NYSE:ELV) · reiterate
- Firm
- Morgan Stanley
- Rating
- Equal-Weight to Equal-Weight
- Price at event
- $445.28
- Market capitalization
- $80.0B
At a glance
Key takeaways
- Morgan Stanley maintained an Equal-Weight rating on Elevance Health Inc. (ELV) on October 22, 2026, suggesting the stock is fairly valued relative to near-term expectations.
Market Context
Elevance Health Inc. operates in the Healthcare sector. The stock currently trades at $445.28 with a market capitalization of $80.0B. The stock has gained 27.0% over the past 52 weeks.
Analyst coverage from Morgan Stanley provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Elevance Health Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Elevance Health Inc.
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 22, 2026 | Barclays | Overweight | N/A |
| Oct 22, 2026 | RBC Capital | Sector Perform | N/A |
| Oct 22, 2026 | Morgan Stanley | Equal-Weight | N/A |
| Oct 22, 2026 | Guggenheim | Buy | N/A |
| Oct 22, 2026 | UBS | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ELV Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for ELV?
A rating of Equal-Weight from Morgan Stanley reflects the analyst's outlook on Elevance Health Inc. (NYSE:ELV). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ELV forecast page.
